Scientists compared 175 different health outcomes between those who took GLP-1 drugs to those who took traditional diabetes medications such as Jardiance. So we decided to do this comprehensive study looking at all 175 possible health outcomes, leaving no stone unturned.” Those using GLP-1 medications also had a reduced risk of seizures, suicidal ideation, self-harm, bulimia, and psychotic disorders such as schizophrenia. Additionally, Al-Aly and his team reconfirmed a potential dementia-protecting benefit when they found participants taking GLP-1 drugs had a decreased risk of neurocognitive conditions such as dementia and Alzheimer’s disease. Scientists also found a link between GLP-1 use and an increased risk of arthritic disorders, pancreatitis, sleep disturbances, hypotension, and nephrolithiasis, normally known as kidney stones.